ライフサイエンスコーパス: intra-arterial infusion

1 oblastoma if administered locally via direct intra-arterial infusion.

2 man protein (rhVEGF-C; 500 microg) by direct intra-arterial infusion.

3 peripheral blood flow in CHF patients after intra-arterial infusion and after oral administration in

4 ar implantation appeared more effective than intra-arterial infusion, and mobilized peripheral blood

5 ycemia (300 mg/dL) created by dextrose (50%) intra-arterial infusion, and with coadministration of vi

6 ncept for CBL0137 and its administration via intra-arterial infusion as a superior treatment compared

7 5.0 mg/kg) were administered as a 10-minute intra-arterial infusion; control animals received vehicl

8 titute CBL0137 in the ILP protocol, using an intra-arterial infusion method, to safely achieve effect

9 Intra-arterial infusion of 17 beta-oestradiol significan

10 local hyperglycemia (300 mg/dL) achieved by intra-arterial infusion of 50% dextrose.

11 responses (strain-gauge plethysmography) to intra-arterial infusion of a selective blocker of ETA re

12 studied the forearm blood flow responses to intra-arterial infusion of acetylcholine (7.5 to 30 micr

13 on plethysmography and blood sampling during intra-arterial infusion of acetylcholine, bradykinin, so

14 lusion plethysmography in response to serial intra-arterial infusion of acetylcholine, sodium nitropr

15 anges in vascular conductance (FVC) to local intra-arterial infusion of ACh (endothelium-dependent di

16 In the present study, intra-arterial infusion of ACh or ATP to augment endothe

17 osine kinase inhibitor-as well as continuous intra-arterial infusion of adenosine.

18 ar conductance (CalfVC) were measured during intra-arterial infusion of an alpha-adrenoreceptor agoni

19 ence of clinical therapeutic angiogenesis by intra-arterial infusion of an angiogenic protein.

20 the nanomolar range and were not reduced by intra-arterial infusion of an angiotensin-converting enz

21 Repetitive intra-arterial infusion of autologous BMMNCs into the co

22 alation study provides evidence of safety of intra-arterial infusion of autologous MSCs in patients w

23 ned to repetitive (3 times; 3-week interval) intra-arterial infusion of BMMNC or placebo.

24 is trial was to determine whether repetitive intra-arterial infusion of bone marrow mononuclear cells

25 (FBF) and net t-PA release before and during intra-arterial infusion of bradykinin (25 to 400 ng/min)

26 Additionally, we demonstrate that intra-arterial infusion of capsaicin results in a dose-r

27 These effects are abrogated by an intra-arterial infusion of corticosterone.

28 Intra-arterial infusion of ET-1 significantly increased

29 Group A (n = 3) underwent intra-arterial infusion of gadolinium 160 ((160)Gd)-labe

30 found in stroke animals that received local intra-arterial infusion of human PRP lysate (p's<0.05).

31 Forearm flow responses to intra-arterial infusion of increasing doses of acetylcho

32 was evaluated by measuring the effects of an intra-arterial infusion of incremental doses of carbacho

33 on of K(IR) channels in quiescent muscle via intra-arterial infusion of KCl independently amplified t

34 elium-dependent vasodilation was assessed by intra-arterial infusion of methacholine (0.3 to 10 micro

35 Using an intra-arterial infusion of N(G) -monomethyl-L -arginine

36 with and without NO synthase inhibition via intra-arterial infusion of N(G) -monomethyl-L -arginine

37 t nitric oxide synthase (NOS) inhibition via intra-arterial infusion of N(G)-monomethyl-L-arginine (L

38 Intra-arterial infusion of N(G)-monomethyl-L-arginine (L

39 ium-independent vasodilation was measured by intra-arterial infusion of nitroprusside (0.3 to 10 micr

40 The intra-arterial infusion of oncolytic adenoviruses warran

41 low (LBF, Doppler ultrasound) and leg VO2 to intra-arterial infusion of phentolamine (PHEN, alpha-adr

42 anges in vascular conductance (FVC) to local intra-arterial infusion of phenylephrine (PE; alpha(1) -

43 tra-arterial pressure via catheter) to local intra-arterial infusion of phenylephrine (PE; alpha1 -ad

44 ted changes in vascular conductance (FVC) to intra-arterial infusion of phenylephrine (PE; alpha1 -ag

45 Hindlimb intra-arterial infusion of pyridoxal phosphate-6-azophen

46 1)-agonist) or NPY (Y1R-agonist) during: (1) intra-arterial infusion of sodium nitroprusside (SNP; ni

47 occlusion plethysmography before and during intra-arterial infusion of the arginase inhibitor N(omeg

48 resistance vessels (blood flow responses to intra-arterial infusion of the endothelium-dependent dil

49 hours after enalapril (20 mg) or placebo, an intra-arterial infusion of the NEP inhibitor thiorphan (

50 acologically enhanced with Mch or reduced by intra-arterial infusion of the nitric oxide inhibitor N(

51 y measuring the effects on venous tone of an intra-arterial infusion of the NO synthase inhibitor N-m

52 ed by use of forearm blood flow responses to intra-arterial infusions of acetylcholine (a vasodilator

53 e above parameters were also assessed during intra-arterial infusions of acetylcholine and bradykinin

54 Agonist-induced vasodilation to incremental intra-arterial infusions of acetylcholine and bradykinin

55 Forearm venous occlusion plethysmography and intra-arterial infusions of acetylcholine and N(G)-monom

56 Forearm blood flow (FBF) responses to intra-arterial infusions of acetylcholine and sodium nit

57 Forearm blood flow (FBF) responses to intra-arterial infusions of acetylcholine, bradykinin, s

58 d 18 black control subjects before and after intra-arterial infusions of acetylcholine, nitroprusside

59 ascular conductance (FVC) responses to local intra-arterial infusions of ACh, ATP, and sodium nitropr

60 ation, and forearm blood flow in response to intra-arterial infusions of endothelial-dependent and -i

61 w (Q, ultrasound Doppler) at rest and during intra-arterial infusions of endothelium-dependent (acety

62 Forearm vascular responses to intra-arterial infusions of endothelium-dependent and -i

63 s occlusion plethysmography before and after intra-arterial infusions of N(G)-monomethyl-l-arginine (

64 otocols, measuring leg vascular responses to intra-arterial infusions of NG-monomethyl-l-arginine (l-

65 sures were also recorded in seven men during intra-arterial infusions of normal saline, phentolamine

66 alpha- and beta-adrenoreceptor blockade via intra-arterial infusions of phentolamine and propranolol

67 and calculated vascular conductance (FVC) to intra-arterial infusions of phenylephrine (alpha(1)-agon

68 ascular conductance (FVC) responses to local intra-arterial infusions of phenylephrine (alpha(1)-agon

69 forearm vascular conductance (FVC) to local intra-arterial infusions of phenylephrine (PE; alpha(1)-

70 sis were randomly assigned (1:1:1) bilateral intra-arterial infusions of placebo on days 1 and 30 (n=

71 Prior close-intra-arterial infusions of tetrodotoxin or hexamethoniu

72 in-gauge plethysmography) responses to local intra-arterial infusions of tyramine (which evokes endog

73 d, first before start of, and then during an intra-arterial infusion to, the muscle preparation of th